The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of healthy immune system development and function across the lifespan; and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious and immune-mediated diseases. Each P01 application submitted to this FOA must include at least two related, synergistic research projects that share a common central theme, focus, and/or overall objective; and an administrative core. A P01 may include scientific cores, if needed for proposed research.
- Application Deadlines: January 24, 2020; June 11, 2020; January 11, 2021; June 11, 2021; January 11, 2022; June 10, 2022.
- AIDS Deadlines: January 9, 2020; May 7, 2020; September 7, 2020; May 7, 2021; September 7, 2021; May 7, 2022; September 7, 2022.
PAR-20-072 Expiration Date: September 8, 2022
Note that the multiple PDs/PIs option may only be used for the overall Program Leader. NIAID does not support multiple Project/Core Leaders for individual Projects and Cores within a multi-project application.